Home NDC 0378-6955 Bexarotene
Product NDC 0378-6955
11-digit product format 003786955
Labeler code 0378
Product ID 0378-6955_6c9b41f4-421f-4ebf-8219-b68e68f75574
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Bexarotene
Dosage form CAPSULE, LIQUID FILLED
Route ORAL
Labeler Mylan Pharmaceuticals Inc.
Application ANDA203174
Marketing category ANDA
Marketing start 2015-07-09
Substance BEXAROTENE
Active strength 75 mg/1
Pharmacologic classes Retinoid [EPC], Retinoids [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A203174-001 BEXAROTENE BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A203174-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 84e616aacf4f…2026-08-18 06:07:40 2026-07 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A203174-001 BEXAROTENE 75MG CAPSULE / ORAL AB 2014-08-12 f41ea6bd6efb…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 43 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Bexarotene
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength BEXAROTENE 75 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0378-6955-01 Bexarotene 100 in 1 BOTTLE, PLASTIC CAPSULE, LIQUID FILLED 100 5
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded BEXAROTENE ACTIVE INGREDIENT A61RXM4375 BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 1 BEXAROTENE ACTIVE MOIETY A61RXM4375 BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 1 BUTYLATED HYDROXYANISOLE INACTIVE INGREDIENT REK4960K2U BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 1 GELATIN INACTIVE INGREDIENT 2G86QN327L BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 1 POLYETHYLENE GLYCOL 400 INACTIVE INGREDIENT B697894SGQ BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 1 POLYSORBATE 20 INACTIVE INGREDIENT 7T1F30V5YH BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 1 POVIDONES INACTIVE INGREDIENT FZ989GH94E BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 1 SORBITOL INACTIVE INGREDIENT 506T60A25R BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 1 WATER INACTIVE INGREDIENT 059QF0KO0R BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0378-6955 BEXAROTENE CAPSULE, LIQUID FILLED [MYLAN PHARMACEUTICALS INC.] 5 Current NDC, Legacy NDC, 1 package rows 20211218_2d1eb4bd-51f9-4c9b-9fb1-0be5e30a3dc5.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0378-6955-01 00378695501 100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0378-6955-01) 2015-07-09 0000-00-00 No No Current